Please click here to see prescribing information for OMNIPAQUE™ (iohexol).
Please click here to see prescribing information for Clariscan™ (gadoterate meglumine).
Please click here to see prescribing information for RAPISCAN™ (regadenoson).
Adverse events should be reported.
Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GE Healthcare at click here
GE HealthCare | Privacy Policy | Update Profile | Contact Us | Unsubscribe
© 2024 GE HealthCare
GE is a trademark of General Electric Company used under trademark license
JB02360UK | 05 - 2023